Mansi Kallem
Medical Oncology · Johnson City, NYNPI 1396178703
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 94.4% of the total across 95 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 28 manufacturers, the largest accounting for just 20.6% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $612, 2.2 times the $284 reported in 2019. That places this record below the midpoint for medical oncology clinicians in NY, where the typical reported total is $4,912.
Across 95 payments — averaging $18.53 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$362
- Pfizer$285
- AbbVie$216
- CSL Behring$112
- Sanofi-aventis U.S. LLC$99
- E.r. Squibb & Sons, L.L.C.$97
- plus $590 from 22 others
What the payments were for
- Food & beverage$1,66194%
- Education$996%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson(2 entities) | 20 | $362 |
| Pfizer | 21 | $285 |
| AbbVie(2 entities) | 10 | $216 |
| CSL Behring | 5 | $112 |
| Sanofi-aventis U.S. LLC | 1 | $99 |
| E.r. Squibb & Sons, L.L.C. | 6 | $97 |
| Novartis | 4 | $74 |
| Genentech USA, Inc. | 4 | $71 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $55 |
| Beone Medicines USA, Inc. | 2 | $43 |
| AstraZeneca | 2 | $40 |
| Eisai Inc. | 2 | $34 |
| Regeneron Healthcare Solutions, Inc. | 1 | $25 |
| Array Biopharma Inc | 1 | $22 |
| Sanofi | 1 | $21 |
| GSK | 1 | $20 |
| Incyte Corporation | 1 | $19 |
| Daiichi Sankyo Inc. | 1 | $18 |
| Exelixis Inc. | 1 | $18 |
| Jazz Pharmaceuticals Inc. | 1 | $17 |
| Sobi, Inc | 1 | $17 |
| Boehringer Ingelheim | 1 | $15 |
| Novo Nordisk | 1 | $14 |
| Puma Biotechnology, Inc. | 1 | $14 |
| Merck | 1 | $14 |
| Genmab U.S., Inc. | 1 | $14 |
| Taiho Oncology, Inc. | 1 | $13 |
| Bristol Myers Squibb | 1 | $13 |
How this compares
$1,760 in reported general payments places this provider in the 40th percentile of 498 medical oncology providers in New York.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Folic Acid | 12 | $26 |
Paid to pharmacies, not to this prescriber.
Other medical oncology in Johnson City
- Craig ThompsonNew York$4.8M
- Andrew SeidmanNew York$1.3M
- Maria TheodoulouAlbany$1.1M
- Joshua RichterNew York$971K
- Edward GelmannNew York$944K
- Anthony MatoIthaca$909K
- Ehsan MalekBuffalo$826K
- Ghassan Abou-AlfaNew York$825K
- Miguel PeralesNew York$769K
- Komal JhaveriNew York$642K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.